[1]
K. Munawar, R. Qazi, and H. S. Sheikh, “Utilisation Patterns and Treatment Outcomes of EGFR-Tyrosine Kinase Inhibitors in EGFR-mutant Advanced Lung Carcinoma in the Pakistani-Asian Population: A Real-world Data Study”, J Cancer Allied Spec, vol. 9, no. 1, Nov. 2022.